Mito Q contains Coenzyme Q10 (Ubidecarenone). Mito Q uses:
HMG CoA reductase inhibitors mediated decreased level of Coenzyme Q10 in blood, Drug induced Myopathy, Protects body against free radical damage with its antioxidant property, Adjuvant therapy in cardiovascular disease especially in angina and congestive heart failure, Immune system depression, Cognitive decline, Useful in the management of Periodontal Disease
|Brand Name:||Mito Q|
|Generic:||Coenzyme Q10 (Ubidecarenone)|
|Therapeutic Class:||Oral nutritional preparations|
|Last Updated:||2020-11-21 18:15:00|
Mito Q contains Coenzyme Q10 (Ubidecarenone) 300.0 Mg. Mito Q doses
The recommended dose of Co-enzyme Q10 is:
For Co-enzyme Q10 deficiency: 150 mg daily.
For mitochondrial disorders: 150-160 mg, or 2 mg/kg/day.
For heart failure in adults: 100 mg per day divided into 2 or 3 doses.
For recent myocardial infarction: 120 mg daily in 2 divided doses.
For high blood pressure: 120-200 mg per day divided into 2 doses.
For isolated systolic hypertension: 60 mg twice daily.
For preventing migraine headache: 100 mg three times daily.
For Parkinsons disease: 300 mg, 600 mg, 1200 mg and 2400 mg per day in 3-4 divided doses.
For infertility in men: 200-300 mg per day.
For muscular dystrophy: 100 mg per day.
Dividing the total daily dose by taking smaller amounts two or three times a day instead of a large amount all at once can help to reduce side effects.
Coenzyme Q10 is well tolerated and having no significant side effects. Mild gastrointestinal symptoms such as nausea, diarrhea and epigastric distress have been reported.
Coenzyme Q10 is an essential cofactor in the mitochondrial electron transport chain, where it accepts electrons from complex I and II, an activity that is vital for the production of ATP.
Supplemental Coenzyme Q10 may improve beta-cell function and glycemic control in type II diabetics. Therefore, those diabetic patients who do use supplemental Coenzyme Q10 should determine by appropriate monitoring if they need to make any adjustments in their diabetic medications.
Warfarin: Supplemental Coenzyme Q10 may decrease the effectiveness of Warfarin.
Statins: The statin drugs are known to decrease Coenzyme Q10 levels in humans.
Doxorubicin: Coenzyme Q10 may increase the cardiotoxicity of doxorubicin.
Antidiabetic medications: Coenzyme Q10 may improve glycemic control in some type II diabetics. If this were to occur, antidiabetic medications might need appropriate adjusting
Because of lack of information on long-term safety, pregnant women and nursing mothers should avoid Coenzyme Q10.
Patients with a known hypersensitivity to any component of this product
Store in a cool & dry place, protect from light & moisture. Keep out of the reach of children.
Mito Q Tablet price in India 756.5